Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Prosthetic heart valves are a device which mimics the function of human heart valves and have a passive mode of functioning; opening and closing of valves are responses to pressure and flow changes within the heart. GlobalData uses proprietary data and analytics to provide a comprehensive report on the prosthetic heart valves market in Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the prosthetic heart valves market in Japan was Abbott Laboratories followed by Artivion, Braile Biomedica, Edwards Lifesciences, Gyrus Capital, Lepu Medical Technology (Beijing), Medtronic and TTK Healthcare.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Prosthetic Heart Valves are for the patients that have a heart valvular disease where they need their valve to be replaced. Prosthetic heart valve includes both Mechanical Heart Valves and Tissue or Biological Heart Valves. Mechanical heart valves are generally made of non–physiological materials with a mobile occluder, which is made of rigid materials. Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible.
See Also:
The prosthetic heart valves market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size prosthetic heart valves in Japan, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
